A global, cross-sectional survey of patient-reported outcomes, disease burden, and quality of life in epidermolysis bullosa simplex

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

twitter: 3 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 23 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Keratinocyte Grafts for Dystrophic Epidermolysis Bullosa Found to Be Safe, Efficacious

HCP Live, 06 Jan 2023

Jodi Y. So, MD The treatment of recessive dystrophic epidermolysis bullosa (RDEB) with gene-corrected autologous keratinocyte…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.